DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Thyroid cancer	R-HSA-9700206	map05216	disopyramide	3114	drug-path
Asthma	R-HSA-444620	map05310	disopyramide	3114	drug-path
Non-small cell lung cancer	R-HSA-5619066	map05223	disopyramide	3114	drug-path
Basal transcription factors	R-HSA-3232118	map03022	disopyramide	3114	drug-path
Cytokine-cytokine receptor interaction	R-HSA-6788467	map04060	disopyramide	3114	drug-path
Endometrial cancer	R-HSA-2077421	map05213	disopyramide	3114	drug-path
GnRH signaling pathway	R-HSA-168638	map04912	disopyramide	3114	drug-path
Allograft rejection	R-HSA-9679028	map05330	disopyramide	3114	drug-path
Colorectal cancer	R-HSA-4791275	map05210	disopyramide	3114	drug-path
Vascular smooth muscle contraction	R-HSA-445355	map04270	disopyramide	3114	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	disopyramide	3114	drug-path
Chronic myeloid leukemia	R-HSA-9680350	map05220	disopyramide	3114	drug-path
Olfactory transduction	R-HSA-9751605	map04740	imipenem	104838	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	imipenem	104838	drug-path
Natural killer cell mediated cytotoxicity	R-HSA-5218921	map04650	imipenem	104838	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	imipenem	104838	drug-path
Cell adhesion molecules (CAMs)	R-HSA-1031690	0	imipenem	104838	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	dorzolamide	5284549	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	dorzolamide	5284549	drug-path
Olfactory transduction	R-HSA-9751605	map04740	dorzolamide	5284549	drug-path